Adenosine receptor antagonists as immunotherapeutic agents for cancer [ 2014 - 2016 ]

Research Grant

Researchers: A/Pr Phillip Darcy (Principal investigator) ,  Dr John Stagg

Brief description We have shown that drugs that block immunosuppressive adenosine receptors can improve anti-tumour immune responses and consequently enhance the effectiveness of chemotherapy. These drugs are already known to be well-tolerated in humans and so have great potential for clinical development. We propose to determine the therapeutic response achieved with these drugs in combination with established cancer treatments involving radiotherapy and immune based therapies.

Funding Amount $AUD 555,779.33

Funding Scheme Project Grants

Notes Standard Project Grant